-
Genomics-based characterization and personalized treatment in pleural and peritoneal mesothelioma
Study
EGAS00001007294
-
Measuring minimal residual disease in acute myeloid leukemia with MASQ
Study
EGAS00001003732
-
Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders
Study
EGAS50000000840
-
Identification_and_functional_validation_of_driver_mutations_in_colorectal_cancer
Study
EGAS00001000044
-
INSPIRE - Investigator-initiated Phase 2 Study of Pembrolizumab Immunological Response in Metastatic Solid Tumors
Study
EGAS00001003280
-
Lung cancer Early Molecular Assessment
Study
EGAS50000000896
-
SCANDARE HNSCC
Study
EGAS50000001158
-
SCANDARE ovarian
Study
EGAS50000001161
-
Whole-genome and transcriptome versus panel sequencing in precision oncology: A translational-clinical comparison
Study
EGAS50000000431
-
an integrated molecular study of clear cell renal cell carcinoma (ccRCC) including whole-genome/exome and RNA sequencing as well as array-based gene expression/copy-number/methylation analyses
Study
EGAS00001000509
-
IDH1 Somatic Mutation Profile in Intrahepatic Cholangiocarcinoma
Study
EGAS50000001638
-
Anti-tumor and Immune Stimulatory Activity of Iberdomide in Myeloma, Including Patients with Cereblon Dysregulation
Study
EGAS50000000265
-
Fresh vs. frozen cell preparations of colorectal cancer single-cell RNA sequencing
Study
EGAS00001003769
-
RNA sequencing of Non-Small Cell Lung Cancer and adjacent normal tissue
Study
EGAS50000000246
-
Whole-genome sequencing of cell-free DNA from pancreatic and breast cancer cohorts for fragmentomic and tumor fraction analysis
Study
EGAS50000001620
-
Targetable ERBB2 Mutations in Neurofibroma/Schwannoma Hybrid Nerve Sheath Tumors
Study
EGAS00001003776
-
Single cell RNA sequencing of 33 primary colorectal cancer
Study
EGAS00001003779
-
Polyomavirus-positive Merkel cell carcinoma derived from a trichoblastoma suggests an epithelial origin of Merkel cell carcinoma
Study
EGAS00001003784
-
PD1-targeted delivery of an IL-2 variant induces a multifaceted anti-tumoral T cell response in human lung cancer
Study
EGAS50000000396
-
Longitudinal analysis of bone marrow heterogeneity reveals the co-evolution of malignant B cells and their T-cell niche supporting follicular lymphoma persistence
Study
EGAS50000001295
-
Multiomic cell-free DNA profiling to inform molecular classification and immunotherapy outcomes in endometrial cancer
Study
EGAS50000001582
-
The chemotherapeutic CX-5461 is extremely mutagenic and may increase cancer risk
Study
EGAS50000000023
-
Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer
Study
EGAS00001006648
-
Biopsy-Derived Organoids in Personalised Early Breast Cancer Care: Challenges of Tumour Purity and Normal Cell Overgrowth Cap Their Practical Utility
Study
EGAS50000000605
-
Molecular profiling reclassifies adult astroblastoma into known and clinically distinct tumor entities with frequent MAPK pathway alterations
Study
EGAS00001003798
-
Single-cell RNA sequencing of human omental tissue in benign and metastatic ovarian cancer
Study
EGAS50000001465
-
Molecular profiles in early onset prostate cancer
Study
EGAS50000001467
-
PTEN homozygous deletion is a negative prognostic factor in Tumor Treating Fields-treated glioblastoma, IDH wildtype patients
Study
EGAS50000001469
-
Single cell sequencing: Capturing the origin and dynamics of chromosomal copy-number heterogeneity
Study
EGAS00001003812
-
Whole-exome sequencing and RNA-seq data of paired normal-tumour samples from MMR-proficient early-onset colorectal cancer patients
Study
EGAS50000001296
-
Genome- and epigenome-driven evolutionary dynamics of tumour-immune coevolution within primary colorectal cancers
Study
EGAS50000001154
-
RNA sequencing of in vitro generated suppressive myeloid cells using parental and Sialidase expressing A549 cancer cell lines
Study
EGAS00001007618
-
Cell-free DNA methylome and fragmentome analysis for disease relapse monitoring in patients with Ewing Sarcoma
Study
EGAS50000001415
-
Intrapatient tumor heterogeneity and clonal evolution in metastatic salivary gland cancer: an autopsy study
Study
EGAS50000001420
-
RNA seq data of 2 lung cancer samples prepared using 2 different RNA-seq library preparation protocols
Study
EGAS50000001419
-
Molecular evolution and clinical trajectories of prostate cancer identifies novel markers for risk stratification - additional data
Study
EGAS00001004884
-
Discovery and validation of an ancillary genomic test of malignancy for primary melanocytic tumors
Study
EGAS50000000887
-
Tumor Profiler Ovarian Study
Study
EGAS50000000885
-
Clonal Evolution and Transcriptional Plasticity Shape Metastatic Dissemination Routes in Prostate Cancer
Study
EGAS50000000927
-
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study
Study
EGAS50000000932
-
Sequencing data of tumor tissue obtained from GANNET53 study patients
Study
EGAS50000000935
-
Development and validation of multivariate predictors of primary endocrine resistance to tamoxifen and aromatase inhibitors in luminal breast cancer reveal drug-specific differences
Study
EGAS50000001102
-
Genomic landscape of poorly differentiated thyroid carcinoma
Study
EGAS50000001134
-
RNA sequencing of untreated head and neck cancer patient-derived xenografts (PDXs) and matched patient tumor tissue.
Study
EGAS50000001595
-
Liquid biopsy-based minimal residual disease monitoring for early risk stratification and decision-making in advanced non-small cell lung cancer
Study
EGAS50000001554
-
Genomic and transcriptomic analysis of thymic epithelial tumors
Study
EGAS00001004227
-
Activation of IL7RA signalling in human B-lymphoid precursors induces pre-leukemia
Study
EGAS00001003979
-
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium.
Study
EGAS00000000082
-
METABRIC
Study
EGAS00000000098
-
METABRIC miRNA landscape
Study
EGAS00000000122